Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
New Drugs for Rheumatoid Arthritis | NEJM
Rituximab - Wikipedia
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab-related Severe Toxicity | SpringerLink
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Biological Therapy for Rheumatoid Arthritis - ppt download
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
B-Cell Targeted Therapies: Clinical Trials Update
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rheumatoid arthritis - The Lancet
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
